$NVCR

Breakthrough In Lung Cancer Treatment: FDA Approves Novocure’s Optune Lua®

$NVCR In a notable advancement in cancer therapy, Novocure (NASDAQ:’NVCR’) has received approval from the U.S. Food and Drug Administration…